Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: Am J Hematol. 2017 Jun 1;92(8):759–763. doi: 10.1002/ajh.24762

Table 2.

Common drug-related adverse events (≥ 10%) observed in N1087 trial.

Grade 1–2 Grade 3–4
hematological toxicity N % N %
Neutropenia 3 23.1 6 46.2
Platelet count decrease 6 46.2 2 15.4
Anemia 7 53.8
Febrile neutropenia 3 23.1

Grade 1–2 Grade 3–4

non-hematological toxicity N % N %
Nausea 6 46.2 1 7.7
Diarrhea 3 23.1 2 15.4
Rash 3 23.1 2 15.4
Vomiting 3 23.1 1 7.7
Hyperglycemia 4 30.8
Mucositis 3 23.1
Fever 2 15.4
Fatigue 2 15.4
Sinus Bradycardia 2 15.4